Cargando…
Treating asthma in the time of COVID
The Precision Interventions for Severe and/or Exacerbation-Prone Asthma clinical trials network is actively assessing novel treatments for severe asthma during the coronavirus disease (COVID-19) pandemic and has needed to adapt to various clinical dilemmas posed by the COVID-19 pandemic. Pharmacolog...
Autores principales: | Carr, Tara F., Fajt, Merritt L., Kraft, Monica, Phipatanakul, Wanda, Szefler, Stanley J., Zeki, Amir A., Peden, David B., White, Steven R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749385/ https://www.ncbi.nlm.nih.gov/pubmed/36528110 http://dx.doi.org/10.1016/j.jaci.2022.12.800 |
Ejemplares similares
-
Asthma and atopy in COVID-19: 2021 updates
por: Carr, Tara F., et al.
Publicado: (2022) -
Gaining Insights into Asthma-related COVID-19 Risk
por: Carr, Tara F., et al.
Publicado: (2021) -
Creation and implementation of SAMPRO™: A school-based asthma management program
por: Lemanske, Robert F., et al.
Publicado: (2016) -
The school environment and asthma in childhood
por: Hauptman, Marissa, et al.
Publicado: (2015) -
Development of New Therapies for Severe Asthma
por: Fajt, Merritt L., et al.
Publicado: (2017)